Login to Your Account



Juno Therapeutics puts ALL trial on hold after additional deaths

By Michael Fitzhugh
Staff Writer

Wednesday, November 23, 2016

Two cases of cerebral edema, both ending in death, led Juno Therapeutics Inc. to put a clinical hold on a phase II trial of its CAR T-cell therapy, JCAR015, for the second time in five months.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription